Education: M.Sc. Biologi, Doctor of Pharmacy.
Experience: Karin Hoogendoorn (born 1970) has 25 years of experience in the pharmaceutical industry, predominantly in the field of advanced therapy medicinal products (ATMPs), monoclonal antibodies and viral vector based vaccines. She has held various roles of increasing responsibility covering chemical, manufacturing and controls (CMC) and regulatory affairs from pre-clinical to commercial phases for small, medium and large pharmaceutical companies in the Netherlands, Switzerland, Sweden and Japan. Currently, she sits on the International Advisory Board of the Swedish Centre for Advanced Medical Products (CAMP).
Dependency: Karin Hoogendoorn is independent in relation to the company, its senior executives and major shareholders.
Shares: 35 500 (including related parties).